
SHIVAM CHEMICALS (BSE SME)
Apr 23, 2024 - Apr 25, 2024
Price | ₹44 - ₹44 |
Premium | ₹2 |
---|---|
Lot size | 3000 |
Allotment | Apr 26, 2024 |
Listing | Apr 30, 2024 |
Category | Lot(s) | Qty | Amount | Reserved |
---|---|---|---|---|
Retail | 1 | 3000 | 132000 | 726 |
HNI | 2 | 6000 | 264000 | 726 |
Last updated on 25 Apr 2024 | 05:57:05 PM
Category | Offered | Applied | Times |
---|---|---|---|
HNIs | 2178000 | 9657000 | 4.43 |
Retail | 2178000 | 19350000 | 8.88 |
Total | 4356000 | 29007000 | 6.66 |
HNI Interest Cost Per Share (7 Days) | |||||
---|---|---|---|---|---|
@7% ₹0.26 | @8% ₹0.3 | @9% ₹0.34 | @10% ₹0.37 | @11% ₹0.41 | @12% ₹0.45 |
IPO Reservation
Investor Category | Shares Offered | No. of Shares |
---|---|---|
Retail | 47.5% | 2178000 |
Other | 47.5% | 2178000 |
Market Maker | 5.04% | 231000 |
Total No. of Shares | 100.0% | 4587000 |
Shivam Chemicals Limited, formerly known as Sun Organosys Private Limited, has made significant strides in the chemical manufacturing and distribution sector since it was founded in 2010. specializes in the production of Poultry Feed Supplement (MBM), Di Calcium Phosphate (Feed Grade), Mono Calcium Phosphate (MCP), Limestone Powder, Soya De-Oiled Cake, and Magnesium Oxide for cattle. With a strong focus on Hydrated Lime production and a diverse product portfolio, Shivam Chemicals has earned a reputation as a trusted and reputed name in the industry. Boasting a robust marketing network, the company has successfully distributed over 2.50 Lakh metric tons of products, exceeding INR 7,500 million in cumulative value. Through strategic expansion initiatives, including the establishment of a wholly-owned subsidiary with substantial manufacturing capacity in Dahej, Gujarat, Shivam Chemicals has demonstrated its commitment to growth and innovation. Accredited by top international regulatory authorities and equipped with state-of-the-art machinery, the company consistently surpasses customer expectations, forging lasting partnerships globally.
IPO Details
Issue Size | 45,87,000 Equity Shares aggregating up to 20.18 cr |
Fresh Issue | 45,87,000 Equity Shares aggregating up to 20.18 cr |
Issue Type | Fixed Price Issue |
Listing At | BSE SME |
Share holding pre issue | 1,24,00,000 Equity Shares |
Share holding post issue | 1,69,87,000 Equity Shares |
Market Maker portion | 2,31,000 Equity Shares Shreni Shares |
Key Performance Indicators
KPI | Dec-23 Consolidated | Mar-23 Consolidated | Mar-22 Standalone |
---|---|---|---|
ROE | 5.13% | 31.55% | 59.20% |
ROCE | 6.19% | 19.88% | 42.35% |
RONW | 5.06% | 26.90% | 45.68% |
D/E | 1.17 | 1.02 | 0.52 |
EPS (basic & Diluted) | 0.57 | 89.36 | 110.93 |
P/BV | 3.9 | ||
P/E Pre IPO | 15.26 |
Financial Statement
Period | Dec-23 Consolidate | Mar-23 Consolidate | Mar-22 Standalone | Mar-21 Standalone |
---|---|---|---|---|
Assets | 3,881.92 | 3,117.68 | 2,368.79 | 993.66 |
Revenue | 10,710.75 | 15,658.34 | 17,798.84 | 9,557.75 |
Profit After Tax | 70.79 | 357.44 | 443.70 | 86.5 |
Net Worth | 1,399.64 | 1,328.35 | 971.41 | 527.71 |
Reserve & surplus | 159.64 | 1288.85 | 931.41 | 487.71 |
Total Borrowing | 1,638.20 | 1,351.37 | 509.50 | 153.39 |
Amount in Lakhs |
Strength Factors
Vertical Integration: Strong control over manufacturing through a wholly-owned subsidiary ensures quality, efficiency, and cost advantages.
Expert Leadership: A highly educated and experienced board and management team drive strategic decision-making and ensure effective governance.
Technological Edge: Leveraging advanced technology grants the company a competitive advantage in productivity, quality, and innovation.
Risk Factors
Capital-Intensive Manufacturing: The subsidiary's manufacturing operations require significant capital investment, posing financial risks if funding becomes insufficient.
Dependency on Product Demand: Revenue heavily relies on demand for animal feed nutrients and chemical products. Any decline in demand could adversely affect financial performance.
Historical and Potential Negative Cash Flows: Previous and potential future negative cash flows may strain liquidity and hinder growth opportunities, impacting overall financial health.
ARYAMAN FINANCIAL SERVICES LIMITED
Tel No.: +91 22 6216 6999
Email: ipo@afsl.co.in
Website: www.afsl.co.in
Investor Grievance Email: feedback@afsl.co.in
Contact Person: Vatsal Ganatra/ Jigar Bhanushali
CAMEO CORPORATE SERVICES LIMITED
Tel.: +91 - 44 – 40020700
E-mail: priya@cameoindia.com
Website: www.cameoindia.com
Contact Person: K. Sreepriya